Livongo pioneered the category of Applied Health Signals™ to empower people with chronic conditions to live better and healthier lives. Livongo’s team of data scientists aggregate and interpret substantial amounts of health data and information to create actionable, personalized, and timely health signals. Livongo is the first company at the intersection of data science, behavior enablement, and clinical impact with the technologies and capabilities to silence Noisy Healthcare™. Our approach is leading to better clinical and financial outcomes while helping create a different and better experience for people with chronic conditions.

C-Suite On Deck

Responsive image

Feature market insights and perspectives from top C-Level executives, elite technology influencers and thought leaders from your company here. This signature initiative has garnered immense support...

Contact Us

Events

Related News

MEDICAL

AVANTGEN ANNOUNCES LICENSING OF ITS ANTI-SARS-COV-2 ANTIBODY CLONES TO IGM BIOSCIENCES FOR COVID-19 THERAPY DEVELOPMENT

AvantGen | January 12, 2021

news image

AvantGen, Inc., a San Diego-based biotechnology organization with a variety of innovation stages for neutralizer revelation and enhancement, and novel NK and T cell engager age, today reported permitting of a board of its anti-SARS-CoV-2 antibody clones to IGM Biosciences for COVID-19 therapy development. Utilizing its novel yeast show framework and huge different human antibody response libraries, AvantGen has distinguished a board of high partiality human monoclonal antibody clo...

Read More

FIRMENICH OPENS NEW BIOTECHNOLOGY AND NATURALS PILOT PLANT AND LABORATORY IN GENEVA

Firmenich | October 01, 2020

news image

Firmenich, the world's largest privately-owned Perfume and Taste company, is proud to announce the opening of its new biotechnology and naturals pilot plant and laboratory in Geneva. Benefiting from the latest digital technology, the facility opens a new era for the development of ingredients and clean label solutions by providing faster speed-to-market and greater flexibility for customer collaboration. Integrated into the Group's flagship ingredients production site at La Plaine, Genev...

Read More

INDUSTRY OUTLOOK

GENOMENON RECOGNIZED BY FROST & SULLIVAN FOR GENOMIC INTELLIGENCE SOLUTIONS AND SOFTWARE FOR PHARMA AND CLINICAL DIAGNOSTICS COMPANIES

prnewswire | May 08, 2023

news image

Frost & Sullivan announced that it has awarded Genomenon with the 2023 Global Technology Innovation Leadership Award. Each year, Frost & Sullivan presents this award to the company that has developed a product with innovative features and functionality that is gaining rapid acceptance in the market. The award recognizes the quality of the solution and the customer value enhancements it enables. Frost & Sullivan market analysts determined that Genomenon excels in many of the cri...

Read More

INDUSTRIAL IMPACT

PORTAL INNOVATIONS EXPANDS CHICAGO OPERATIONS TRIPLES SPACE IN FULTON LABS

Portal Innovations | February 03, 2022

news image

Portal Innovations continues its momentum in Chicago by launching the second phase of its operations with the opening of 35,000 square feet of premier wet and dry lab and office space at 400 North Aberdeen in Fulton Labs. The new facility will allow Portal, a life sciences venture development engine, to grow and scale its investment in early-stage biotech companies in Chicago. Portal has tapped Patrick Flavin to serve as President of its flagship Chicago operation. With over 20 ye...

Read More
news image

MEDICAL

AVANTGEN ANNOUNCES LICENSING OF ITS ANTI-SARS-COV-2 ANTIBODY CLONES TO IGM BIOSCIENCES FOR COVID-19 THERAPY DEVELOPMENT

AvantGen | January 12, 2021

AvantGen, Inc., a San Diego-based biotechnology organization with a variety of innovation stages for neutralizer revelation and enhancement, and novel NK and T cell engager age, today reported permitting of a board of its anti-SARS-CoV-2 antibody clones to IGM Biosciences for COVID-19 therapy development. Utilizing its novel yeast show framework and huge different human antibody response libraries, AvantGen has distinguished a board of high partiality human monoclonal antibody clo...

Read More
news image

FIRMENICH OPENS NEW BIOTECHNOLOGY AND NATURALS PILOT PLANT AND LABORATORY IN GENEVA

Firmenich | October 01, 2020

Firmenich, the world's largest privately-owned Perfume and Taste company, is proud to announce the opening of its new biotechnology and naturals pilot plant and laboratory in Geneva. Benefiting from the latest digital technology, the facility opens a new era for the development of ingredients and clean label solutions by providing faster speed-to-market and greater flexibility for customer collaboration. Integrated into the Group's flagship ingredients production site at La Plaine, Genev...

Read More
news image

INDUSTRY OUTLOOK

GENOMENON RECOGNIZED BY FROST & SULLIVAN FOR GENOMIC INTELLIGENCE SOLUTIONS AND SOFTWARE FOR PHARMA AND CLINICAL DIAGNOSTICS COMPANIES

prnewswire | May 08, 2023

Frost & Sullivan announced that it has awarded Genomenon with the 2023 Global Technology Innovation Leadership Award. Each year, Frost & Sullivan presents this award to the company that has developed a product with innovative features and functionality that is gaining rapid acceptance in the market. The award recognizes the quality of the solution and the customer value enhancements it enables. Frost & Sullivan market analysts determined that Genomenon excels in many of the cri...

Read More
news image

INDUSTRIAL IMPACT

PORTAL INNOVATIONS EXPANDS CHICAGO OPERATIONS TRIPLES SPACE IN FULTON LABS

Portal Innovations | February 03, 2022

Portal Innovations continues its momentum in Chicago by launching the second phase of its operations with the opening of 35,000 square feet of premier wet and dry lab and office space at 400 North Aberdeen in Fulton Labs. The new facility will allow Portal, a life sciences venture development engine, to grow and scale its investment in early-stage biotech companies in Chicago. Portal has tapped Patrick Flavin to serve as President of its flagship Chicago operation. With over 20 ye...

Read More